DE69413325T2 - 24-Epi-1alpha-Hydroxyvitamin D2 zur Behandlung von Osteoporosis - Google Patents

24-Epi-1alpha-Hydroxyvitamin D2 zur Behandlung von Osteoporosis

Info

Publication number
DE69413325T2
DE69413325T2 DE69413325T DE69413325T DE69413325T2 DE 69413325 T2 DE69413325 T2 DE 69413325T2 DE 69413325 T DE69413325 T DE 69413325T DE 69413325 T DE69413325 T DE 69413325T DE 69413325 T2 DE69413325 T2 DE 69413325T2
Authority
DE
Germany
Prior art keywords
hydroxyvitamin
1alpha
epi
osteoporosis
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69413325T
Other languages
English (en)
Other versions
DE69413325D1 (de
Inventor
Hector F Deluca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Publication of DE69413325D1 publication Critical patent/DE69413325D1/de
Application granted granted Critical
Publication of DE69413325T2 publication Critical patent/DE69413325T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69413325T 1993-07-13 1994-07-13 24-Epi-1alpha-Hydroxyvitamin D2 zur Behandlung von Osteoporosis Expired - Fee Related DE69413325T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9122393A 1993-07-13 1993-07-13

Publications (2)

Publication Number Publication Date
DE69413325D1 DE69413325D1 (de) 1998-10-22
DE69413325T2 true DE69413325T2 (de) 1999-04-29

Family

ID=22226681

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69413325T Expired - Fee Related DE69413325T2 (de) 1993-07-13 1994-07-13 24-Epi-1alpha-Hydroxyvitamin D2 zur Behandlung von Osteoporosis

Country Status (4)

Country Link
EP (1) EP0634173B1 (de)
JP (1) JPH0753384A (de)
DE (1) DE69413325T2 (de)
ES (1) ES2120573T3 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19916419B4 (de) * 1999-04-08 2005-06-16 Schering Ag Kombinationspräparat aus Vitamin-D-Metaboliten oder Vitamin-D-Analoga und einem Östrogenpartialagonisten zur Behandlung von Osteoporose

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588716A (en) * 1984-05-04 1986-05-13 Wisconsin Alumni Research Foundation Method for treating metabolic bone disease in mammals
CA1341408C (en) * 1988-08-02 2002-12-10 Charles W. Bishop Method for treating and preventing loss of bone mass
US4973584A (en) * 1989-03-09 1990-11-27 Deluca Hector F Novel 1α-hydroxyvitamin D2 epimer and derivatives

Also Published As

Publication number Publication date
DE69413325D1 (de) 1998-10-22
EP0634173A1 (de) 1995-01-18
ES2120573T3 (es) 1998-11-01
JPH0753384A (ja) 1995-02-28
EP0634173B1 (de) 1998-09-16

Similar Documents

Publication Publication Date Title
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69427869D1 (de) Botulinumtoxine zur behandlung von hyperhydrosis
DE69318693D1 (de) Magnetischer Konditionierer zur Behandlung von Flüssigkeiten
DE69412552T2 (de) Medizinisches Instrument zur Behandlung von Sinusitis
ITRM940150A0 (it) Procedimento per il trattamento di acque di scarico fortemente colorate.
DE69404785T2 (de) Vorrichtung zur Behandlung von Oberflächen
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
DE69421196D1 (de) Vorrichtung zur behandlung von überbiss
DE69527140D1 (de) Wirkstoff zur prävention oder behandlung von osteoporose
DE69426848T2 (de) Gerät zur Behandlung von lichtempfindlichen Materialien
DE69702997D1 (de) Verfahren zur Behandlung von verunreinigtem Aluminiumoxid
DE69405919T2 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69737067D1 (de) Vakzine zur behandlung von mycosen
DE69420229T2 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
DE69403871D1 (de) Vorrichtung zur Behandlung von Oberflächen
DE69408394T2 (de) 4-Piperidino-piperidin zur Behandlung von Tumoren
DE69412178D1 (de) Apparat zur Behandlung von Lagen
DE69806062T2 (de) Kombinationstherapie zur behandlung von aids
ATE235494T1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
DE69413325D1 (de) 24-Epi-1alpha-Hydroxyvitamin D2 zur Behandlung von Osteoporosis
DE69306260T2 (de) Behandlung von abwasser
ATA93695A (de) Mittel zur behandlung von strahlenschäden
DE68918449D1 (de) Siliziumverbindungen zur behandlung von knochen.
DE59712374D1 (de) Verwendung von hcc-1 zur behandlung von thrombozytopenien

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee